Status:
COMPLETED
The Role of TVSG and HS in Determining Endometrial Pathologies
Lead Sponsor:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Abnormal Uterine Bleeding
Eligibility:
FEMALE
21-51 years
Phase:
NA
Brief Summary
Although hysteroscopy (HS) and transvaginal ultrasonography (TVSG) are methods in the diagnosis of AUB, there is some suspicion about their efficacy. The aim of this study was to determine the efficac...
Eligibility Criteria
Inclusion
- patients who have no history of hysteroscopy and curettage,
- patients who have no history of ovulatory dysfunction
- women who have active vaginal bleeding.
Exclusion
- presence of genital infections/PID
- presence of pregnancy
- presence of vaginal or cervical pathology causing vaginal bleeding
- women who are receiving hormonal treatment (COC/HRT)
- patients formerly diagnosed with endometrial pathology
- patients having coagulopathy
- women who are using intrauterine device.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2011
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT03441087
Start Date
January 1 2011
End Date
December 31 2011
Last Update
February 26 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.